Central Serous Retinopathy or Central Serous Chorioretinopathy causes the vision to get blurred and distorted. It is caused due to collection of fluid under the Macula. Macula is the small central portion of the retina. The retina is the light-sensing nerve tissue, which is at the back of the eye, while macula helps us in our vision related tasks which require fine detailing (such as reading, watching TV and using PCs and mobile devices).
Central Serous Retinopathy (CSR) happens when there is a break in the Retinal Pigment Epithelium (RPE). RPE is one of the several layers that makes up Retina. RPE separates the light-sensitive part of the retina from the choroid. The choroid is a layer of blood vessels that lies underneath the retina. The RPE prevents fluid and blood from the choroid building up under your retina. Due to the break in RPE, fluid begins to collect under the retina leading to swelling of the Macula. This leads to the vision becoming blurred and distorted.
Mostly, CSR affects only one eye. It can affect both men and women. However, men between the age of 30 and 50 are more likely to develop CSR than women. The specific reasons for a person to develop CSR are not known (because of which CSR is also called idiopathic CSR). However, persons with certain traits have more chances to get CSR. There is increased possibility of CSR in the following conditions:
The eye specialist will use specialised equipment such as Slit lamp and Indirect Ophthalmoscope to examine the patient’s eye focusing on the retina and the macula. The doctor shall administer dilating eye drops to the patient’s eyes about 30 minutes prior to examination. The dilating eye drops help in pupil dilation (i.e. to widen / stretch the pupils in the eye). The dilated pupil shall help the doctor to analyse the retina and macula in a better and easy way. The effect of the eye drop may take 4 to 6 hours to wear off completely.
Based on the diagnosis, the doctor may want to conduct further tests for reconfirming the initial diagnosis and to establish the extent of the disease
Optical Coherence Topography (OCT) – It is a quick, non-touch, non-invasive and painless imaging method. During OCT, a scan of the affected eye is conducted by asking the patient to look into a source of light for a particular duration of time. The scan provides a cross sectional view of the various layers of the retina and a comprehensive view of the macula. This enables the doctor to determine the amount of fluid deposited in the macula and establish the level of swelling of the macula.
Fundus Fluorescein Angiography (FFA or FA) – In FFA, photos/ images are taken of the network of bloods vessels which are under the retina. This enables the doctor to determine the leakages. It often takes less than 30 minutes. The procedure is as follows:
Your eye doctor or an assistant will put drops in the eyes to dilate (widen) the pupil.
A yellowish coloured dye (fluorescein) is injected in a vein, usually in the arm. It takes about 10–15 seconds for the dye to travel throughout the body. While this is painless, some people may feel sick. The dye eventually reaches the blood vessels in the eye, which causes them to “fluoresce” or shine brightly.
As the dye passes through the retina, a special fundus camera takes pictures. This enables the doctor to determine the leakages. The angiography will reveal fluorescent spots with fluid leakage
In many cases, Central Serous Retinopathy (CSR) improves on its own and there is no long-term impact on the vision. Non-steroidal anti-inflammatory drugs like Nepafenac eyedrops and oral Spironolactone have an important role in treating CSR. However, in some cases where CSR continues for long, it can impact vision. Further treatment is considered if CSR tends to persist after 4 to 6 months of initial diagnosis which may include
Disclaimer: All information, provided above is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider. Read our full disclaimer here.